223 related articles for article (PubMed ID: 30867323)
1. "Inactive" ingredients in oral medications.
Reker D; Blum SM; Steiger C; Anger KE; Sommer JM; Fanikos J; Traverso G
Sci Transl Med; 2019 Mar; 11(483):. PubMed ID: 30867323
[TBL] [Abstract][Full Text] [Related]
2. The extra-phosphate intestinal load from medications: is it a real concern?
Cupisti A; Moriconi D; D'Alessandro C; Verde F; Marchini M; Saba A; Egidi MF
J Nephrol; 2016 Dec; 29(6):857-862. PubMed ID: 27084800
[TBL] [Abstract][Full Text] [Related]
3. Oral absorption enhancement: taking the next steps in therapeutic delivery.
Brayden DJ; Maher S
Ther Deliv; 2010 Jul; 1(1):5-9. PubMed ID: 22816114
[No Abstract] [Full Text] [Related]
4. Delayed Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review.
Caballero ML; Quirce S
J Investig Allergol Clin Immunol; 2020; 30(6):400-408. PubMed ID: 32376520
[TBL] [Abstract][Full Text] [Related]
5. Are excipients really inert ingredients? A review of adverse reactions to excipients in oral dermatologic medications in Canada.
Noiles K; Vender R
J Cutan Med Surg; 2010; 14(3):105-14. PubMed ID: 20487670
[TBL] [Abstract][Full Text] [Related]
6. Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review.
Cutaia K; Chablani L; Zhao F
Int J Pharm Compd; 2018; 22(6):480-489. PubMed ID: 30384349
[TBL] [Abstract][Full Text] [Related]
7. Basics of compounding foam dosage forms.
Allen LV
Int J Pharm Compd; 2013; 17(4):312-22. PubMed ID: 24261147
[TBL] [Abstract][Full Text] [Related]
8. The Most Useful Pharmaceutical Formulations (Individualized Medications) in Pediatric Dermatology: A Review.
Abarca Lachén E; Hernando Martínez P; Gilaberte Calzada Y
Actas Dermosifiliogr (Engl Ed); 2021 Apr; 112(4):302-313. PubMed ID: 33220314
[TBL] [Abstract][Full Text] [Related]
9. Basics of Compounding with Dilutions and Concentrates.
Allen LV
Int J Pharm Compd; 2017; 21(1):39-45. PubMed ID: 28346197
[TBL] [Abstract][Full Text] [Related]
10. Biologic excipients: Importance of clinical awareness of inactive ingredients.
Ionova Y; Wilson L
PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
[TBL] [Abstract][Full Text] [Related]
11. The impact of common pharmaceutical excipients on the gut microbiota.
Subramaniam S; Kamath S; Ariaee A; Prestidge C; Joyce P
Expert Opin Drug Deliv; 2023; 20(10):1297-1314. PubMed ID: 37307224
[TBL] [Abstract][Full Text] [Related]
12. The activities of drug inactive ingredients on biological targets.
Pottel J; Armstrong D; Zou L; Fekete A; Huang XP; Torosyan H; Bednarczyk D; Whitebread S; Bhhatarai B; Liang G; Jin H; Ghaemi SN; Slocum S; Lukacs KV; Irwin JJ; Berg EL; Giacomini KM; Roth BL; Shoichet BK; Urban L
Science; 2020 Jul; 369(6502):403-413. PubMed ID: 32703874
[TBL] [Abstract][Full Text] [Related]
13. Advances in Polymer Design for Enhancing Oral Drug Solubility and Delivery.
Ting JM; Porter WW; Mecca JM; Bates FS; Reineke TM
Bioconjug Chem; 2018 Apr; 29(4):939-952. PubMed ID: 29319295
[TBL] [Abstract][Full Text] [Related]
14. Basics of Compounding: Compounding Films.
Allen LV
Int J Pharm Compd; 2016; 20(4):298-305. PubMed ID: 28333675
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
[TBL] [Abstract][Full Text] [Related]
16. Anaphylaxis to Excipients in Current Clinical Practice: Evaluation and Management.
Bruusgaard-Mouritsen MA; Nasser S; Garvey LH; Krantz MS; Stone CA
Immunol Allergy Clin North Am; 2022 May; 42(2):239-267. PubMed ID: 35469617
[TBL] [Abstract][Full Text] [Related]
17. Contact allergy to ingredients of topical medications: results of the European Surveillance System on Contact Allergies (ESSCA), 2009-2012.
Uter W; Spiewak R; Cooper SM; Wilkinson M; Sánchez Pérez J; Schnuch A; Schuttelaar ML
Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1305-1312. PubMed ID: 27464585
[TBL] [Abstract][Full Text] [Related]
18. Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules.
Dijkers E; Nanhekhan V; Thorissen A; Polonini H
Int J Pharm Compd; 2017; 21(2):171-175. PubMed ID: 28346214
[TBL] [Abstract][Full Text] [Related]
19. Choosing a medication brand: Excipients, food intolerance and prescribing in older people.
Page A; Etherton-Beer C
Maturitas; 2018 Jan; 107():103-109. PubMed ID: 29169573
[TBL] [Abstract][Full Text] [Related]
20. [Sample and titer of pharmaceutical forms].
Setnikar I
Boll Chim Farm; 1968 Mar; 107(3):168-72. PubMed ID: 5730324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
